CHENG ANDREW (President and CEO) sold 5.4% of their position (30K shares) of AKERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.62M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/14/2025ACC: 0001193125-25-239343
DirectorOfficer· President and CEO
Since Jun 2019
-30K
Net shares
Net seller
$1.62M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$19.87
Trade value
$596.10K
% of position
5.7%
10/10/2025
526.11K→556.11K
Common Stock
Direct
Shares
−30K
Price / share
$53.98
Trade value
$1.62M
% of position
5.4%
10/10/2025
556.11K→526.11K
Total
Net shares
+0.00
Net value
-$1.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2025 | M · Option Exercise | +30K | $19.87 | $596.10K | 5.7% | 526.11K | 556.11K |
| Common Stock Direct | 10/10/2025 | S · Sale | −30K | $53.98 | $1.62M | 5.4% | 556.11K | 526.11K |
| Total | +0.00 | -$1.02M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
19.87
Held after
380.02K
Exercisable
—
10/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30K shares | 10/10/2025 | M · Option Exercise | −30K | 19.87 | — | 380.02K |